Economic evaluation on infant hepatitis B vaccination combined with immunoglobulin in China, 2013

Hum Vaccin Immunother. 2016 Jul 2;12(7):1838-46. doi: 10.1080/21645515.2016.1141845. Epub 2016 Feb 18.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • China
  • Cost of Illness
  • Cost-Benefit Analysis
  • Hepatitis B / prevention & control*
  • Hepatitis B Vaccines / economics
  • Hepatitis B Vaccines / therapeutic use*
  • Humans
  • Immunoglobulins / economics
  • Immunoglobulins / therapeutic use*
  • Infant
  • Infectious Disease Transmission, Vertical / prevention & control
  • Vaccination / economics*

Substances

  • Hepatitis B Vaccines
  • Immunoglobulins